← Home
/
Zentalis Pharmaceuticals, Inc. (ZNTL)
Stock Analysis
Zentalis Pharmaceuticals, Inc. (ZNTL)
ZNTL
ZNTL · Market data
3.70
+2.21%
Updated: 2026-06-21 10:04 UTC
WOI Investment Thesis
Mixed
Confirmation improves above 3.73. Holding above 2.87 keeps the current thesis intact.
✓
Fundamentals
Weak / Insufficient
×
Breakout Confirmation
Pending
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
2.87
↗
Break Above
Confirmation improves above resistance.
3.73
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 2.87
What's Driving ZNTL?
📈 Technical recovery is improving
Momentum is Neutral. Watch 3.73 for confirmation and 2.87 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 2.87
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
◎
How to read this setup
The nearest decision zone is framed by support around 2.93 and resistance near 3.72. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
●
Profitability
Insufficient
📈 Net Income
-35.35M
≈ Insufficient
🧮 EPS (Basic)
-0.50
≈ Insufficient
Zentalis Pharmaceuticals, Inc.
Note: This is an algorithmic technical snapshot, not financial advice.